Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Bullboard Posts
Post by Noloon May 13, 2019 12:38pm
227 Views
Post# 29740909

ICYMI - Annual and special meeting

ICYMI - Annual and special meetingThere was this post on SEDAR, dated May 10th, confirming the date of the annual meeting on June 12th. So, I guess we are going to have a busy and interesting month ahead. 

''VIA ELECTRONIC TRANSMISSION TO ALL APPLICABLE EXCHANGES AND COMMISSIONS: RE: GENENEWS LIMITED Revised Confirmation of Notice of Record and Meeting Dates We are pleased to confirm that Notice of Record and Meeting Dates was sent to The Canadian Depository for Securities. We advise the following with respect to the upcoming Annual and Special Meeting of Security Holders for the subject issuer:

1 ISIN: CA36870T2065
   CUSIP: 36870T206
2 Date Fixed for the Meeting: June 12, 2019
3 Record Date for Notice: May 6, 2019
4 Record Date for Voting: May 6, 2019
5 Beneficial Ownership Determination Date: May 6, 2019
6 Classes or Series of Securities that entitle the holder to receive Notice of the Meeting: COMMON
7 Classes or Series of Securities that entitle the holder to vote at the meeting: COMMON
8 Business to be conducted at the meeting: Annual and Special
9 Notice-and-Access:
           Registered Shareholders: NO
           Beneficial Holders: NO
           Stratification Level: Not Applicable
10 Reporting issuer is sending proxy-related materials directly to Non-Objecting Beneficial Owners: YES
11 Issuer paying for delivery to Objecting Beneficial Owners: YES''


Bullboard Posts